Decreased percentage of CD4+Foxp3+TGF-β+ and increased percentage of CD4+IL-17+ cells in bronchoalveolar lavage of asthmatics

Journal of Inflammation (United Kingdom)

Volumn 11, Issue 1, 2014, Pages

  Barczyk, Adam ^a   Pierzchala, Wladyslaw ^a   Caramori, Gaetano ^b   Wiaderkiewicz, Ryszard ^a   Kaminski, Marcin ^a   Barnes, Peter J ^c   Adcock, Ian M ^c  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b UNIVERSITY OF FERRARA   (Italy)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Asthma; BAL; CD4+Foxp3+TGF + cells; CD4+IL 17+ cells

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHOSCOPY; CD4 LYMPHOCYTE PERCENTAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG LAVAGE; LYMPHOCYTE FUNCTION; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

EID: 84908060572     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-11-22     Document Type: Article

References (44)

1. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA). 2011 Available from [ http://www.ginasthma.org ] Date last updated. 2011
2. The cytokine network in asthma and chronic obstructive pulmonary disease. Barnes PJ, J Clin Invest 2008 118 3546 3556
3. Immunology of asthma and chronic obstructive pulmonary disease. Barnes PJ, Nat Rev Immunol 2008 8 183 192
4. Natural versus adaptive regulatory T cells. Bluestone JA, Abbas AK, Nat Rev Immunol 2003 3 253 257
5. [The use of multi-color flow cytometry for identification of functional markers of nTregs in patients with severe asthma]. Kraszula L, Eusebio MO, Kupczyk M, Kuna P, Pietruczuk M, Pneumonol Alergol Pol 2012 80 389 401
6. How do regulatory T cells work? Corthay A, Scand J Immunol 2009 70 326 336
7. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ, J Exp Med 2007 204 1765 1774
8. Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma. McGee HS, Agrawal DK, Am J Respir Crit Care Med 2009 180 211 225
9. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Horwitz DA, Zheng SG, Gray JD, Trends Immunol 2008 29 429 435
10. Natural and induced CD4 + CD25+ cells educate CD4+. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA, J Immunol 2004 172 5213 5221
11. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Li MO, Sanjabi S, Flavell RA, Immunity 2006 25 455 471
12. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. Carrier Y, Yuan J, Kuchroo VK, Weiner HL, J Immunol 2007 178 179 185
13. A protective role for periostin and TGF-beta in IgE-mediated allergy and airway hyperresponsiveness. Gordon ED, Sidhu SS, Wang ZE, Woodruff PG, Yuan S, Solon MC, Conway SJ, Huang X, Locksley RM, Fahy JV, Clin Exp Allergy 2012 42 144 155
14. The family of IL-10-secreting CD4+ T cells. Fujio K, Okamura T, Yamamoto K, Adv Immunol 2010 105 99 130
15. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4 + CD25+ regulatory T cells. Vieira PL, Christensen JR, Minaee S, O'Neill EJ, Barrat FJ, Boonstra A, Barthlott T, Stockinger B, Wraith DC, O'Garra A, J Immunol 2004 172 5986 5993
16. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. Batten M, Kljavin NM, Li J, Walter MJ, de Sauvage FJ, Ghilardi N, J Immunol 2008 180 2752 2756
17. Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. Miyara M, Wing K, Sakaguchi S, J Allergy Clin Immunol 2009 123 749 755
18. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Maynard CL, Harrington LE, Janowski KM, Oliver JR, Zindl CL, Rudensky AY, Weaver CT, Nat Immunol 2007 8 931 941
19. Induction of type 2 T helper cell allergen tolerance by IL-10-differentiated regulatory dendritic cells. Li X, Yang A, Huang H, Zhang X, Town J, Davis B, Cockcroft DW, Gordon JR, Am J Respir Cell Mol Biol 2010 42 190 199
20. Quantitative and functional impairment of pulmonary CD4 + CD25hi regulatory T cells in pediatric asthma. Hartl D, Koller B, Mehlhorn AT, Reinhardt D, Nicolai T, Schendel DJ, Griese M, Krauss-Etschmann S, J Allergy Clin Immunol 2007 119 1258 1266
21. Decreased FOXP3 protein expression in patients with asthma. Provoost S, Maes T, van Durme YM, Gevaert P, Bachert C, Schmidt-Weber CB, Brusselle GG, Joos GF, Tournoy KG, Allergy 2009 64 1539 1546
22. Increased airway T regulatory cells in asthmatic subjects. Smyth LJ, Eustace A, Kolsum U, Blaikely J, Singh D, Chest 2010 138 905 912
23. Allergen provocation increases TH2-cytokines and FOXP3 expression in the asthmatic lung. Thunberg S, Gafvelin G, Nord M, Gronneberg R, Grunewald J, Eklund A, van Hage M, Allergy 2010 65 311 318
24. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. Akdis M, Palomares O, van de Veen W, van Splunter M, Akdis CA, J Allergy Clin Immunol 2012 129 1438 1449
25. Transforming growth factor-beta induces development of the T(H)17 lineage. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT, Nature 2006 441 231 234
26. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK, Nature 2006 441 235 238
27. IL-17A produced by alphabeta T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Kudo M, Melton AC, Chen C, Engler MB, Huang KE, Ren X, Wang Y, Bernstein X, Li JT, Atabai K, Huang X, Sheppard D, Nat Med 2012 18 547 554
28. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J, J Allergy Clin Immunol 2001 108 430 438
29. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, Ceuppens JL, Respir Res 2006 7 135
30. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Barczyk A, Pierzchala W, Sozanska E, Respir Med 2003 97 726 733
31. Interleukin 17 and RANTES levels in induced sputum of patients with allergic rhinitis after a single nasal allergen challenge. Semik-Orzech A, Barczyk A, Wiaderkiewicz R, Pierzchala W, Ann Allergy Asthma Immunol 2009 103 418 424
32. T(H)17-associated cytokines (IL-17A and IL-17 F) in severe asthma. Al-Ramli W, Prefontaine D, Chouiali F, Martin JG, Olivenstein R, Lemiere C, Hamid Q, J Allergy Clin Immunol 2009 123 1185 1187
33. Expression of the T helper 17-associated cytokines IL-17A and IL-17 F in asthma and COPD. Doe C, Bafadhel M, Siddiqui S, Desai D, Mistry V, Rugman P, McCormick M, Woods J, May R, Sleeman MA, Anderson IK, Brightling CE, Chest 2010 138 1140 1147
34. Cytokine production by bronchoalveolar lavage T lymphocytes in chronic obstructive pulmonary disease. Barczyk A, Pierzchala W, Kon OM, Cosio B, Adcock IM, Barnes PJ, J Allergy Clin Immunol 2006 117 1484 1492
35. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Wakashin H, Hirose K, Maezawa Y, Kagami S, Suto A, Watanabe N, Saito Y, Hatano M, Tokuhisa T, Iwakura Y, Puccetti P, Iwamoto I, Nakajima H, Am J Respir Crit Care Med 2008 178 1023 1032
36. Phenotypic and functional features of human Th17 cells. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Fili L, Ferri S, Frosali F, Giudici F, Romagnani P, Parronchi P, Tonelli F, Maggi E, Romagnani S, J Exp Med 2007 204 1849 1861
37. Plasticity of CD4+ T cell lineage differentiation. Zhou L, Chong MM, Littman DR, Immunity 2009 30 646 655
38. Plasticity of T-cell phenotype and function: the T helper type 17 example. Peck A, Mellins ED, Immunology 2010 129 147 153
39. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE, Eur J Immunol 2007 37 129 138
40. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Allan SE, Crome SQ, Crellin NK, Passerini L, Steiner TS, Bacchetta R, Roncarolo MG, Levings MK, Int Immunol 2007 19 345 354
41. Induction of FOXP3 expression in naive human CD4 + FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Tran DQ, Ramsey H, Shevach EM, Blood 2007 110 2983 2990
42. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Ayyoub M, Deknuydt F, Raimbaud I, Dousset C, Leveque L, Bioley G, Valmori D, Proc Natl Acad Sci U S A 2009 106 8635 8640
43. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Williams LM, Rudensky AY, Nat Immunol 2007 8 277 284
44. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Wan YY, Flavell RA, Nature 2007 445 766 770